Antares Pharma Inc | TalkMarkets

Article By: SmithOnStocks

Monday, September 25, 2017 4:19 PM EDT

In this report I update my objectives and include several buy recommendations in the biotech sphere.

In this article: CYTK, AIS, NWBO, PTLA, RGEN, CYRX, BMY, ALIM, AGEN, EYPT, AMAG, WINT, AMGN, GNE, BIIB

Article By: SmithOnStocks

Thursday, March 23, 2017 3:16 PM EDT

Antares has an impressive portfolio of seven new products that could lead to explosive growth over the next four years.

In this article: AIS